CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 22 filers reported holding CONMED CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $39,560,164 | +6.0% | 32,244,000 | 0.0% | 0.12% | -29.2% |
| Q3 2023 | $37,322,430 | +11.2% | 32,244,000 | +48.3% | 0.17% | +1.2% |
| Q2 2023 | $33,550,992 | +62.4% | 21,744,000 | +29.9% | 0.17% | +59.6% |
| Q1 2023 | $20,653,724 | +13.5% | 16,744,000 | +4.7% | 0.10% | -21.8% |
| Q4 2022 | $18,201,172 | +10.5% | 15,994,000 | +6.9% | 0.13% | +34.3% |
| Q3 2022 | $16,470,000 | +64.5% | 14,959,000 | +81.2% | 0.10% | +102.0% |
| Q2 2022 | $10,012,000 | -89.2% | 8,254,000 | -84.7% | 0.05% | -80.9% |
| Q1 2022 | $93,024,000 | +17.5% | 53,974,000 | +13.7% | 0.26% | +93.9% |
| Q4 2021 | $79,163,000 | +25.4% | 47,474,000 | +16.6% | 0.13% | +5.6% |
| Q3 2021 | $63,148,000 | +12.5% | 40,724,000 | +17.3% | 0.12% | -1.6% |
| Q2 2021 | $56,123,000 | +240.9% | 34,724,000 | +230.7% | 0.13% | +159.2% |
| Q1 2021 | $16,465,000 | – | 10,500,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,035,000 | $4,888,000 | 0.98% |
| III Capital Management | 3,669,000 | $4,453,000 | 0.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 3,972,000 | $4,789,000 | 0.29% |
| MACKAY SHIELDS LLC | 6,783,000 | $8,195,000 | 0.20% |
| Warberg Asset Management LLC | 722,000 | $875,000 | 0.19% |
| ZAZOVE ASSOCIATES LLC | 1,628,000 | $1,967,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,564,000 | $4,312,000 | 0.12% |
| Teton Advisors, Inc. | 350,000 | $423,000 | 0.09% |
| Calamos Wealth Management LLC | 823,000 | $998,000 | 0.09% |
| WESTWOOD HOLDINGS GROUP INC | 4,310,000 | $5,263,000 | 0.06% |